Paragon Care Limited · ASX:PGC
Paragon Care — Shareholder Meeting (November 2015)
17 slides from Paragon Care's shareholder meeting presentation, Nov 30, 2015
Slide 1: Paragon Care Limited – 2015 Annual General Meeting
30 November 2015 Australian Securities Exchange Company Announcements Office Paragon Care Limited – 2015 Annual General Meeting Chairman’s Address and Managing Director’s Presentation Paragon Care Limited (“Company”) is convening its 2015 Annual General Meeting today, 30 November 2015, in Melbourne.
Slide 2: Chairman's Address – 2015 Annual General Meeting
30 November 2015 Australian Securities Exchange Company Announcements Office CHAIRMAN’S ADDRESS – 2015 ANNUAL GENERAL MEETING Good morning ladies and gentlemen. Welcome to the 2015 annual general meeting of Paragon Care. My name is Shane Tanner and I am the chairman of your company. Thank you for yo
Slide 3: Chairman's Address (continued)
The capital raising was oversubscribed and highly successful. We welcomed several new institutional investors onto the register. We would like to thank all shareholders who participated in the subsequent entitlement offer for supporting Paragon. Pleasingly, we also entered into a new secured senior
Slide 4: AGM Presentation
AGM Presentation 30 November 2015 PGC:ASX
Slide 5: Company Highlights
COMPANY HIGHLIGHTS A unique exposure to a rapidly emerging health care company Paragon is now one of the premier medical equipment and consumables suppliers on the ASX Platform economics and a customer focused business model differentiate Paragon’s service offering and provide a valuable first mover
Slide 6: Company Overview
COMPANY OVERVIEW Update financial information and share price chart Paragon is transforming the health care procurement sector Corporate overview Share price performance Share price ($) Volume (m) A premium provider of medical equipment and 0.80 3.00 consumables throughout Australia and New Zealand
Slide 7: Trading Update
TRADING UPDATE FY15 was a record year for Paragon FY15 highlights FY15 financials (excl. three acquisitions) FY15 was a rewarding year for Paragon and its shareholders with Δ since FY14 the share price up 127% over the period Revenue $32.2m ↑ 66% Characterised by strong operating performance from co
Slide 8: FY16 Outlook
FY16 OUTLOOK Recent performance driving positive outlook for FY16 Last 12 months share price performance FY16 outlook Share price ($) Reaffirming expectations of double digit earnings growth 0.80 Focus on generating strong organic growth and 0.70 integrating the three recent acquisitions ― Paragon’s
Slide 9: Acquisitions Update
ACQUISITIONS UPDATE All three value-enhancing acquisitions have now successfully settled The three recent acquisitions have strengthened Paragon’s proportion of consumables revenue and provided further geographic diversification Leading supplier of medical and Diagnostic and surgical product Provide
Slide 10: Integration Update
INTEGRATION UPDATE Designs for Vision is the main integration focus Most streamlined business out of the three acquisitions with minimal integration required Operationally the business has continued as is with the immediate focus on sales/marketing and finance Full product suite will be channelled i
Slide 11: Pro-Forma Financials
PRO-FORMA FINANCIALS Post capital raising pro-forma consolidated revenues are now $100m+ Capital raising summary Debt financing Institutional placement fully underwritten by Bell Potter New debt financing with a major Australian bank raised $35.0m $23m acquisition finance 1 for 5 non-renounceable ri
Slide 12: Platform Economics
PLATFORM ECONOMICS Platform is designed to make procurement easier for the customer Key point of difference that is analogous to the investment wrap / platform concept which successfully transformed the investment management sector Paragon has lead the way in Australia adoptin platform economics to
Slide 13: Business Model
BUSINESS MODEL High end products provides stable revenue and repeat customers Value proposition to customers is based on a platform offering of high quality products and premium customer service around those products Key competitive advantage and the point of differentiation that drives repeat purch
Slide 14: Board and Management
BOARD AND MANAGEMENT Experienced Board and management team with a proven track record Paragon’s Chairman Shane Tanner is a renowned leader in the health care industry, having been the Chairman of Vision Eye Institute (VEI.ASX) since it formed in 2001 Highly experienced Board and management team with
Slide 15: Founder's Story
FOUNDER’S STORY Key management personnel have contributed to Paragon’s growth since 2008 Share price performance clearly demonstrates management’s ability to execute value enhancing transactions Events post new management appointment Share price(A$) Volume (m) 0.75 20.0 Date Event August 2015 Mark S
Slide 16: Share Price Catalysts
SHARE PRICE CATALYSTS Operational and corporate events to provide ongoing share price catalysts Revenue synergies and cost-outs from recent acquisitions should INTEGRATION support strong earnings growth over time Mitigating risk New opportunities for product sales Integration onto SAP occurring over
Slide 17: Disclaimer
DISCLAIMER Some of the statements in this presentation constitute “forward-looking statements” that do not directly or exclusively relate to historical facts. These forward-looking statements reflect Paragon Care Limited’s current intentions, plans, expectations, assumptions and beliefs about future